NCT05636592View on ClinicalTrials.gov

Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

October 15, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2027

Conditions
Lung Cancer
Interventions
DRUG

immunotherapy

statin combined with immunotherapy

Trial Locations (1)

310000

The Fourth Affiliated Hospital of Zhejiang University, Yiwu

All Listed Sponsors
collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

lead

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

OTHER